Novel Products and Ingredients for Implementation in Antimicrobial Applications for Use on Skin

RB (www.rb.com) a Global FSTE top 20 FMCG company with businesses in Health, Hygiene and Nutrition are seeking novel products and ingredients which could be used for antimicrobial applications. 

Areas of Interest: RB are interested in technologies, products and approaches which fall into one of the following categories:

• Antibacterial/Antiviral/Antifungal/Antimicrobial/Antiseptic properties.
• Superior germ protection (e.g. faster acting, stronger acting, longer lasting, more convenient, safer, more sustainable etc.).
• Germ “management” (e.g. prevention of adhesion, transfer or biological control).
• Free from “harsh” chemicals.
• Novel ingredients (e.g. food grade, natural germ killers etc.).
• Kind on skin (e.g. non‑drying, moisturising etc.).
• New usage occasions.
• Manipulation of skin microbiome.
• Temporary physical coating applied to the skin.

Submitted opportunities must satisfy the following criteria:

• Differentiation from products/technologies currently on the market.
• Inclusion of scientific data to support efficacy, preferably via EN, ASTM or other standard in-vitro or in-vivo test methods.
• Inclusion of skin safety data (or defined route to generate).
• Application to any format (e.g. spray, liquid, sachet, powder, foam, pump, wipe etc.).
• Should have clear regulatory pathway to commercialisation

Stage of Development: Ready to license technologies are of particular interest, however submission of opportunities at all stages of development are encouraged, as longer term developments are also of interest.

Submission Information: Technologies are to be submitted using the submission form found here. Submission of one page, 200-300 word Research Project, Spinout and Centre‑of‑Excellence briefs are also encouraged. In submitting to this campaign you confirm that your submission contains only non-confidential information.

Opportunity for Collaboration: Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case by case basis. Example outcomes include licensing assets, project/PhD funding, and research collaborations.